The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD (NCT06414356)
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD: A Prospective Randomized Design
🩺 Plain-English Summary (8th-Grade Level)
This study is aimed to evaluate outpatient ketamine infusion within a military chronic neuropathic pain population and its effect on PTSD. Currently, this is a pilot study with 30 participants. Participants will be randomized to (1) a moderate dose ketamine, (2) moderate dose ketamine +Mg, or (3) a magnesium control group. Participants will complete self-reported pain and PTSD questionnaires throughout the \~24-week study period. The outlined strategy will provide evidence for the utility of ketamine in neuropathic pain management and pain associated comorbidities within a military population.
Who can join: Review the eligibility criteria below.
Location: Brooke Army Medical Center — San Antonio, Texas
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Brooke Army Medical Center — San Antonio, Texas
📞 Contact the Study Coordinator
Phone: (210) 473-7447
Email: margaux.m.salas.ctr@health.mil
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Neuropathic Pain
- Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain — Baltimore, Maryland
- Simultaneous Engagement of Networks for Alleviating Pain (SENAP) — Minneapolis, Minnesota
- Daily, Encapsulated, Green Tea Extract to Mitigate Neuropathic Pain in Patients With Established Cancer-Associated Neuropathic Pain — Birmingham, Alabama
- Ultrasound for Peripheral Nerve Modulation — Stanford, California
- Brain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study — Cleveland, Ohio
- Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain — San Diego, California
Explore by condition: All Neuropathic Pain clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.